Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0065 | 1 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |